NCT04214366
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +11 more
- Locations
-
- University of Heidelberg, Radiooncology, HIT Heidelberg, Germany
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,074 public trials
1,189 recruiting studies
Adenocarcinoma trial results
NCT04745403
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
- Locations
-
- Singapore General Hospital Singapore
NCT06126406
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +40 more
- Locations
-
- The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
NCT06010862
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +37 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT06010875
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +35 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Hunan Provincial People's Hospital Changsha, Hunan, China
NCT05550961
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NCT06056115
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital) Shijiazhuang, Hebei, China
NCT06044506
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cipto Mangunkusumo General Hospital Jakarta Pusat, Jakarta Special Capital Region, Indonesia
Recruiting
SIRT for Potentially Resectable HCC
NCT05994859
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China